Amy Welsh Agile Therapeutics Inc (AGRX) insider trading activity

AGRX Quotes by TradingView

Amy Welsh is Chief Commercial Officer of AGILE THERAPEUTICS INC. Currently has a direct ownership of 0 shares of AGRX, which is worth approximately $0. The most recent transaction as insider was on Aug 26, 2024, when has been sold 13,500 shares (Common Stock) at a price of $1.52 per share, resulting in proceeds of $20,520. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Amy Welsh Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 26 2024
SELL
Sale (or disposition) back to the issuer
$20,520 $1.52 p/Share
13,500 Reduced 100.0%
0 Common Stock
Jun 28 2023
BUY
Grant, award, or other acquisition
-
13,500 Added 50.0%
13,500 Common Stock
AW

Amy Welsh

Chief Commercial Officer
Princeton, NJ

Track Institutional and Insider Activities on AGRX

Follow AGILE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGRX shares.

Notify only if

Insider Trading

Get notified when an Agile Therapeutics Inc insider buys or sells AGRX shares.

Notify only if

News

Receive news related to AGILE THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGRX